esorubicin has been researched along with Carcinoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gralla, RJ; Heelan, RT; Kris, MG; Marks, LD; Rigas, JR | 1 |
| Bagatella, M; Bonardi, G; Calciati, A; Donadio, M; Giaccone, G | 1 |
1 trial(s) available for esorubicin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Doxorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1991 |
1 other study(ies) available for esorubicin and Carcinoma, Small Cell
| Article | Year |
|---|---|
4'-Deoxydoxorubicin, an inactive drug in small cell lung cancer.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Doxorubicin; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1987 |